Andreas Marneros1, Frank Pillmann, Tobias Wustmann. 1. Department of Psychiatry, Psychotherapy, and Psychosomatics, Martin Luther University of Halle-Wittenberg, Julius-Kühn-Strasse 7, 06097 Halle/Saale, Germany. andreas.marneros@medizin.uni-halle.de
Abstract
OBJECTIVES: This article tries to give an answer to the question of whether International Classification of Diseases (ICD-10) persistent delusional disorder (PDD) or Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) delusional disorder (DD) is simply paranoid schizophrenia (PS). Because ICD-10 PDD and DSM-IV DD are identical, we use DD as a synonym. METHODS: A prospective and longitudinal study compared all inpatients with DD treated at the Halle-Wittenberg university hospital during a 14-year period with a previously investigated selected cohort of patients with PS. Sociodemographic data, symptomatology, course, and outcome parameters were examined using standardized instruments. The duration of the follow-up period in patients with DD was 10.8 years and for the PS patients 12.9 years. RESULTS: Significant differences between DD and PS were found: DD patients are, in comparison to patients with PS, significantly older at onset. Less of their first-degree relatives have mental disorders. They less frequently come from a broken home situation. First-rank symptoms, relevant negative symptoms, and primary hallucinations did not occur in patients with DD. Patients with DD were less frequently hospitalized, and the duration of their hospitalization was shorter. Their outcome is much better regarding employment, early retirement due to the disorder, and psychopharmacological medication. They more often had stable heterosexual partnerships and were autarkic. They had lower scores in the Disability Assessment Scale and in Positive and Negative Syndrome Scale. The diagnosis of DD is very stable over time. CONCLUSIONS: The findings of this study support the assumption that DDs are a separate entity and only exceptionally can be a prodrome of schizophrenia.
OBJECTIVES: This article tries to give an answer to the question of whether International Classification of Diseases (ICD-10) persistent delusional disorder (PDD) or Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) delusional disorder (DD) is simply paranoid schizophrenia (PS). Because ICD-10 PDD and DSM-IV DD are identical, we use DD as a synonym. METHODS: A prospective and longitudinal study compared all inpatients with DD treated at the Halle-Wittenberg university hospital during a 14-year period with a previously investigated selected cohort of patients with PS. Sociodemographic data, symptomatology, course, and outcome parameters were examined using standardized instruments. The duration of the follow-up period in patients with DD was 10.8 years and for the PS patients 12.9 years. RESULTS: Significant differences between DD and PS were found: DD patients are, in comparison to patients with PS, significantly older at onset. Less of their first-degree relatives have mental disorders. They less frequently come from a broken home situation. First-rank symptoms, relevant negative symptoms, and primary hallucinations did not occur in patients with DD. Patients with DD were less frequently hospitalized, and the duration of their hospitalization was shorter. Their outcome is much better regarding employment, early retirement due to the disorder, and psychopharmacological medication. They more often had stable heterosexual partnerships and were autarkic. They had lower scores in the Disability Assessment Scale and in Positive and Negative Syndrome Scale. The diagnosis of DD is very stable over time. CONCLUSIONS: The findings of this study support the assumption that DDs are a separate entity and only exceptionally can be a prodrome of schizophrenia.
Authors: M J Hilsenroth; S J Ackerman; M D Blagys; B D Baumann; M R Baity; S R Smith; J L Price; C L Smith; T L Heindselman; M K Mount; D J Holdwick Journal: Am J Psychiatry Date: 2000-11 Impact factor: 18.112
Authors: Karishma R Kulkarni; Rashmi Arasappa; Krishna M Prasad; Amit Zutshi; Prabhat K Chand; Kesavan Muralidharan; Pratima Murthy Journal: Prim Care Companion CNS Disord Date: 2016-02-04
Authors: José Eduardo Muñoz-Negro; Inmaculada Ibáñez-Casas; Enrique de Portugal; Vanessa Lozano-Gutiérrez; Rafael Martínez-Leal; Jorge A Cervilla Journal: Can J Psychiatry Date: 2017-06-08 Impact factor: 4.356
Authors: Pak Wing Calvin Cheng; Wing Chung Chang; Gladys G Lo; Kit Wa Sherry Chan; Ho Ming Edwin Lee; Lai Ming Christy Hui; Yi Nam Suen; Yim Lung Eric Leung; Kai Ming Paul Au Yeung; Sirong Chen; Ka Fung Henry Mak; Pak Chung Sham; Barbara Santangelo; Mattia Veronese; Chi-Lai Ho; Yu Hai Eric Chen; Oliver D Howes Journal: Neuropsychopharmacology Date: 2020-07-01 Impact factor: 7.853
Authors: Alexandre González-Rodríguez; Mary V Seeman; Alexandre Díaz-Pons; Rosa Ayesa-Arriola; Mentxu Natividad; Eva Calvo; José A Monreal Journal: J Clin Med Date: 2022-08-04 Impact factor: 4.964